CSIMarket


Chemed Corporation  (NYSE: CHE)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare

Chemed Corporation

CHE's Fundamental analysis








Looking into Chemed growth rates, revenue grew by 9.79 % in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 189

Healthcare Facilities industry recorded growth of revenues by 3.49 %

Chemed's net income grew by 10.37 % in first quarter of 2025 year on year, above company average,

More on CHE's Growth


Chemed
current PE on trailing twelve month basis is above Healthcare Facilities industry average.

Chemed PEG ratio is at 2.57 Chemed realized cash reduction of $ -9.45 per share in trailing twelve-month period.
Company
28.22
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.44.
Healthcare Facilities industry's Price to Sales ratio is at 1.13.


More on CHE's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 1.89 $
 Dividend Yield TTM (%) 0.34 %
 Revenue/Employee (TTM) $ 164,976
 Net Income/Employee (TTM) $ 20,464
 Receivable Turnover (TTM) 11.87
 Tangible Book Value (Per Share $) 28.78

Chemed
current PE on trailing twelve month basis is above Healthcare Facilities industry average.

Chemed PEG ratio is at 2.57 Chemed realized cash outflow of $ -9.45per share in trailing twelve-month period.
Company
28.22
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 3.44.
Healthcare Facilities industry's Price to Sales ratio is at 1.13.

Chemed Price to Book Ratio is at 7.24 lower than Industry Avg. of 228.76. and higher than S&P 500 Avg. of 0.01

More on CHE's Valuation

  Market Capitalization (Millions $) 8,561
  Shares Outstanding (Millions) 15
  Employees 15,087
  Revenues (TTM) (Millions $) 2,489
  Net Income (TTM) (Millions $) 309
  Cash Flow (TTM) (Millions $) -139
  Capital Exp. (TTM) (Millions $) -51
  Total Debt (Millions $) -
  Dividend TTM ($) 1.89 $
  Dividend Yield TTM (%) 0.34 %
  Revenue/Employee (TTM) $ 164,976
  Net Income/Employee(TTM) $ 20,464
  Receivable Turnover Ratio (TTM) 11.87
  Tangible Book Value (Per Share $) 28.78

  Market Capitalization (Millions $) 8,561
  Shares Outstanding (Millions) 15
  Employees 15,087
  Revenues (TTM) (Millions $) 2,489
  Net Income (TTM) (Millions $) 309
  Cash Flow (TTM) (Millions $) -139
  Capital Exp. (TTM) (Millions $) -51


    CHE's Profitability Comparisons
Chemed faced margin deterioration, primarily through cost pressure. Operating Margin fell in first quarter of 2025 to 14.65 % from 17.79 % in IV. Quarter.

Chemed net profit margin of 11.09 % is currently ranking no. 4 in Healthcare Facilities industry, ranking no. 74 in Healthcare sector and number 955 in S&P 500.


Profitability by Segment
VITAS 15.41 %
Roto-Rooter 20.21 %
Total 11.09 %



  Ratio
   Capital Ratio (MRQ) 1.73
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 1.28
  Asset Turnover Ratio (TTM) 1.56
  Inventory Turnover Ratio (TTM) 177.22



Chemed faced margin deterioration, primarily through cost pressure. Operating Margin fell in first quarter of 2025 to 14.65 % from 17.79 % in IV. Quarter.

Chemed net profit margin of 11.09 % is currently ranking no. 4 in Healthcare Facilities industry, ranking no. 74 in Healthcare sector and number 955 in S&P 500.

More on CHE's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com